| COALITION FOR ENERGY ASSISTANCE MODERNIZATION | FORBES-TATE | Q3 2026 | Energy/Nuclear, Budget/Appropriations |
| WALGREENS CO. | FORBES-TATE | Q3 2026 | Taxation/Internal Revenue Code, Medicare/Medicaid, Health Issues |
| VIR BIOTECHNOLOGY, INC. | FORBES-TATE | Q3 2026 | Health Issues |
| I AM ALS | FORBES-TATE | Q3 2026 | Medical/Disease Research/Clinical Labs, Veterans, Health Issues |
| TENNESSEE RURAL HEALTH IMPROVEMENT ASSOCIATION | FORBES-TATE | Q3 2026 | Health Issues |
| PHRMA | FORBES-TATE | Q3 2026 | Trade (domestic/foreign), Medicare/Medicaid, Health Issues |
| NOVARTIS, INC. | FORBES-TATE | Q3 2026 | Trade (domestic/foreign), Budget/Appropriations, Taxation/Internal Revenue Code |
| ELI LILLY AND COMPANY FKA LILLY USA, LLC | FORBES-TATE | Q3 2026 | Medicare/Medicaid, Health Issues, Budget/Appropriations |
| GENENTECH | FORBES-TATE | Q3 2026 | Budget/Appropriations, Taxation/Internal Revenue Code, Medicare/Medicaid |
| AMGEN USA, INC. | FORBES-TATE | Q3 2026 | Taxation/Internal Revenue Code, Medicare/Medicaid, Medical/Disease Research/Clinical Labs |
| AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION | FORBES-TATE | Q3 2026 | Financial Institutions/Investments/Securities, Medical/Disease Research/Clinical Labs, Budget/Appropriations |
| ALEXION PHARMACEUTICALS, INC. | FORBES-TATE | Q3 2026 | Medicare/Medicaid, Health Issues |
| NORTHPORT HEALTH SERVICES | FORBES-TATE | Q3 2026 | Medicare/Medicaid, Health Issues, Budget/Appropriations |
| NATIONAL ASSOCIATION OF PROTON THERAPY | FORBES-TATE | Q3 2026 | Veterans, Medicare/Medicaid, Health Issues |
| INDEPENDENT PHARMACY COOPERATIVE | FORBES-TATE | Q3 2026 | Budget/Appropriations, Medicare/Medicaid, Health Issues |
| GLOBAL MEDICAL RESPONSE | FORBES-TATE | Q3 2026 | Medicare/Medicaid, Health Issues, Veterans |
| STRATHSPEY CROWN HOLDINGS, LLC | FORBES-TATE | Q2 2026 | Health Issues |
| TARSUS PHARMACEUTICALS | FORBES-TATE | Q1 2026 | Health Issues |
| GILEAD SCIENCES, INC. | FORBES-TATE | Q1 2026 | Health Issues |
| ANTIMICROBIAL INNOVATION ALLIANCE | FORBES-TATE | Q4 2025 | Health Issues |
| REVANGENIX | FORBES-TATE | Q4 2025 | Health Issues |
| BIO-RAD LABORATORIES | FORBES-TATE | Q3 2025 | Defense, Medicare/Medicaid, Health Issues |
| OPTIONS CLEARING CORPORATION (OCC) | FORBES-TATE | Q3 2025 | Financial Institutions/Investments/Securities |
| HEALTHY.IO (US), INC. | FORBES-TATE | Q2 2025 | Medicare/Medicaid, Health Issues |
| CYTOVALE, INC. | FORBES-TATE | Q1 2025 | Medicare/Medicaid, Health Issues |